C-reactive protein in patients with Guillain Barré syndrome
Author(s) -
Chetana Vaishnavi,
Prashant Kapoor,
Chitra Behura,
ShrawanKumar Singh,
Sudesh Prabhakar
Publication year - 2014
Publication title -
indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/0377-4929.130897
Subject(s) - guillain barre syndrome , medicine , group b , gastroenterology , context (archaeology) , group a , campylobacter jejuni , immunology , population , biology , environmental health , paleontology , genetics , bacteria
C-reactive protein (CRP) is an acute phase reactant, widely used as a biomarker for various infectious and inflammatory conditions. Guillain-Barrι syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy, triggered by infectious agents such as Campylobacter jejuni. GBS is generally precipitated 1-3 weeks following C. jejuni infection which suggests a humoral immunopathogenic mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom